Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Burden, Epidemiology, and Clinical Characteristics of Leptospirosis within the United States Military Health System.

Created on 24 Jun 2026

Authors

Patrick J Graf, Xiuping Chu, Julian Davies, Patrick W Hickey, Dana M Blyth

Published in

The American journal of tropical medicine and hygiene. Jun 23, 2026. Epub Jun 23, 2026.

Abstract

Leptospirosis is a global zoonosis with varying severity that remains underreported due to diagnostic limitations. We analyzed the burden, epidemiology, and clinical characteristics of leptospirosis diagnoses in the Military Health System, which includes care to more than 1.3 million active-duty service members and 6.5 million retirees and dependents worldwide. Potential diagnoses were identified by leptospirosis-specific ICD-9 and ICD-10 codes or laboratory tests between January 1, 2013 and December 31, 2021. Upon chart review they were classified per U.S. CDC case definitions. Of 296 identified potential leptospirosis cases, there were 11 confirmed, 134 probable, and 53 possible cases. The majority of cases were young adult males. Japan, Guam, and Hawaii were the most common areas of exposure. Most cases were associated with freshwater exposures, both from recreational and occupational exposures (including a significant number associated with jungle warfare training in Okinawa). Confirmed cases were statistically more likely to be diagnosed in Hawaii. This study from a worldwide distributed unified health system reaffirms the global distribution and wide range of clinical severity of leptospirosis. It highlights the relatively few confirmed diagnoses in the setting of diagnostic limitations even in a population already presumed to be at elevated risk. Strategies and improved diagnostics are needed to shift clinician practice to pursue confirmatory testing, particularly in cases with a high suspicion or high-risk of exposure. Recent improvements in availability and performance of various testing methodologies (multiplex polymerase chain reaction based-assays and serological testing) may further define the epidemiology of this global disease.

PMID:
42335880
Bibliographic data and abstract were imported from PubMed on 24 Jun 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 1
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement